Boston Trust Walden’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Sell
42,442
-645
-1% -$34K 0.01% 268
2026
Q1
$2.64M Sell
43,087
-5
-0% -$358 0.02% 253
2025
Q4
$3.58M Buy
43,092
+230
+0.5% +$17.2K 0.03% 235
2025
Q3
$2.87M Sell
42,862
-51,357
-55% -$3.71M 0.02% 239
2025
Q2
$7.35M Sell
94,219
-28,630
-23% -$2.19M 0.05% 218
2025
Q1
$9.4M Sell
122,849
-9,160
-7% -$746K 0.07% 205
2024
Q4
$10.2M Sell
132,009
-550
-0.4% -$43K 0.07% 205
2024
Q3
$10.2M Sell
132,559
-130
-0.1% -$9.68K 0.07% 204
2024
Q2
$9.02M Sell
132,689
-2,250
-2% -$153K 0.07% 201
2024
Q1
$9.89M Sell
134,939
-330
-0.2% -$25.2K 0.07% 195
2023
Q4
$10.2M Sell
135,269
-1,500
-1% -$104K 0.08% 192
2023
Q3
$9.26M Buy
136,769
+20,100
+17% +$1.39M 0.08% 195
2023
Q2
$7.62M Buy
116,669
+29,285
+34% +$1.81M 0.06% 210
2023
Q1
$5.32M Sell
87,384
-11,566
-12% -$724K 0.05% 225
2022
Q4
$5.66M Buy
98,950
+25,340
+34% +$1.49M 0.05% 225
2022
Q3
$4.23M Buy
73,610
+4,970
+7% +$326K 0.04% 234
2022
Q2
$4.63M Buy
68,640
+17,815
+35% +$1.36M 0.04% 233
2022
Q1
$4.56M Sell
50,825
-3,425
-6% -$301K 0.04% 238
2021
Q4
$4.81M Buy
54,250
+14,525
+37% +$1.17M 0.04% 245
2021
Q3
$2.95M Buy
39,725
+1,445
+4% +$107K 0.03% 245
2021
Q2
$2.65M Sell
38,280
-58,340
-60% -$4.34M 0.02% 253
2021
Q1
$7.55M Sell
96,620
-10
-0% -$773 0.07% 216
2020
Q4
$7.92M Buy
96,630
+1,775
+2% +$135K 0.08% 212
2020
Q3
$6.58M Buy
94,855
+19,925
+27% +$1.3M 0.08% 218
2020
Q2
$4.26M Buy
74,930
+69,330
+1,238% +$3.72M 0.06% 239
2020
Q1
$260K Sell
5,600
-1,438
-20% -$85.7K ﹤0.01% 330
2019
Q4
$436K Sell
7,038
-705
-9% -$43.6K 0.01% 333
2019
Q3
$467K Sell
7,743
-74,615
-91% -$4.72M 0.01% 327
2019
Q2
$5.22M Sell
82,358
-117,024
-59% -$7.68M 0.07% 232
2019
Q1
$14.4M Buy
199,382
+12,180
+7% +$853K 0.2% 148
2018
Q4
$11.9M Sell
187,202
-8,910
-5% -$620K 0.19% 158
2018
Q3
$15.1M Sell
196,112
-1,670
-0.8% -$131K 0.21% 136
2018
Q2
$15.6M Sell
197,782
-115
-0.1% -$9.04K 0.23% 134
2018
Q1
$15.9M Sell
197,897
-2,195
-1% -$173K 0.24% 123
2017
Q4
$14.2M Buy
200,092
+3,035
+2% +$222K 0.21% 142
2017
Q3
$14.3M Sell
197,057
-21,290
-10% -$1.5M 0.22% 135
2017
Q2
$14.5M Sell
218,347
-4,540
-2% -$288K 0.23% 130
2017
Q1
$13.3M Sell
222,887
-3,770
-2% -$217K 0.21% 157
2016
Q4
$12.7M Sell
226,657
-6,515
-3% -$349K 0.2% 166
2016
Q3
$11.1M Buy
233,172
+4,560
+2% +$259K 0.18% 168
2016
Q2
$13.1M Buy
228,612
+16,983
+8% +$1.03M 0.22% 159
2016
Q1
$13.3M Buy
211,629
+16,173
+8% +$940K 0.23% 160
2015
Q4
$11.7M Buy
195,456
+60,005
+44% +$3.87M 0.22% 160
2015
Q3
$8.48M Buy
135,451
+120,822
+826% +$7.58M 0.14% 199
2015
Q2
$894K Sell
14,629
-800
-5% -$50.2K 0.01% 294
2015
Q1
$963K Sell
15,429
-50
-0.3% -$2.95K 0.01% 286
2014
Q4
$815K Sell
15,479
-225
-1% -$11.2K 0.01% 296
2014
Q3
$703K Hold
15,704
0.01% 297
2014
Q2
$768K Hold
15,704
0.01% 290
2014
Q1
$795K Sell
15,704
-100
-0.6% -$5K 0.01% 267
2013
Q4
$798K Hold
15,804
0.01% 271
2013
Q3
$649K Sell
15,804
-50
-0.3% -$1.86K 0.01% 271
2013
Q2
$497K Buy
+15,854
New +$527K 0.01% 273

Other funds holding CTSH

Boston Trust Walden's CTSH Position: Q2 2026 in Review

Boston Trust Walden reduced its Cognizant (CTSH) stake by 1.5% in Q2 2026, selling an estimated $34K and leaving 42,442 shares worth $1.64M. The position accounts for 0.01% of the portfolio, ranked #268.

Boston Trust Walden first reported a position in CTSH in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.9M in Q1 2018. 303 funds tracked by Wall St. Rank hold CTSH as of Q2 2026.

  • Boston Trust Walden held 42,442 shares of Cognizant worth $1.64M as of Q2 2026.
  • Boston Trust Walden sold 645 Cognizant shares in Q2 2026, an estimated $34K.
  • Cognizant made up 0.01% of Boston Trust Walden's portfolio in Q2 2026, its #268 holding.
  • Boston Trust Walden first reported a position in Cognizant in Q2 2013 and has held it in 53 quarters since.
  • Boston Trust Walden's Cognizant position peaked at $15.9M in Q1 2018.
  • 303 funds tracked by Wall St. Rank held Cognizant as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.